What is the treatment for male urethritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Male Urethritis

For male urethritis, first-line treatment is azithromycin 1g orally in a single dose or doxycycline 100mg orally twice daily for 7 days. 1

Diagnosis

Before initiating treatment, confirm urethritis with at least one of the following:

  • Mucopurulent or purulent urethral discharge 1
  • Positive leukocyte esterase test on first-void urine 1
  • ≥10 WBC per high-power field on microscopic examination of first-void urine sediment 1

All patients with confirmed or suspected urethritis should be tested for:

  • Neisseria gonorrhoeae 1
  • Chlamydia trachomatis 1

Treatment Algorithm

First-line Treatment Options

  • Azithromycin 1g orally in a single dose 1, 2
    • Advantages: Single-dose regimen improves compliance and allows for directly observed therapy 1
    • Particularly effective against Mycoplasma genitalium 1

OR

  • Doxycycline 100mg orally twice daily for 7 days 1
    • Highly effective for chlamydial urethritis 1

Alternative Regimens (if first-line options cannot be used)

  • Erythromycin base 500mg orally four times a day for 7 days 1
  • Erythromycin ethylsuccinate 800mg orally four times a day for 7 days 1
  • Levofloxacin 500mg orally once daily for 7 days 1
  • Ofloxacin 300mg orally twice a day for 7 days 1

Special Considerations

Empiric Treatment

  • Empiric treatment without documentation of urethritis is recommended only for patients at high risk for infection who are unlikely to return for follow-up 1
  • In such cases, treat for both gonorrhea and chlamydia 1

Partner Management

  • All sex partners within the preceding 60 days should be referred for evaluation and treatment 1
  • Partners should receive treatment effective against chlamydia regardless of whether a specific etiology is identified in the index patient 1
  • Expedited partner treatment is an alternative approach 1

Post-Treatment Instructions

  • Abstain from sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen 1
  • Sexual abstinence should continue until symptoms have resolved 1
  • Sexual partners should be treated before resuming sexual activity 1

Management of Persistent or Recurrent Urethritis

If symptoms persist or recur after treatment:

  1. Confirm objective signs of urethritis before initiating further antimicrobial therapy 1, 3
  2. Rule out non-compliance with initial treatment or re-exposure to untreated partner 1, 3
  3. If compliant with initial regimen and re-exposure excluded, recommended treatment is:
    • Metronidazole 2g orally in a single dose OR Tinidazole 2g orally in a single dose 1
    • PLUS
    • Azithromycin 1g orally in a single dose (if not used for initial episode) 1

Common Pitfalls to Avoid

  • Treating based on symptoms alone without confirming objective signs of urethritis 1, 3
  • Failing to test for both gonorrhea and chlamydia 1
  • Not addressing possible reinfection from untreated partners 1, 3
  • Overlooking the possibility of tetracycline-resistant Ureaplasma urealyticum or Mycoplasma genitalium in persistent cases 1
  • Ignoring the need for follow-up if symptoms persist 1

Follow-Up

  • Patients should return for evaluation if symptoms persist or recur after treatment 1
  • Persistence of pain, discomfort, and irritative voiding symptoms beyond 3 months should prompt evaluation for chronic prostatitis/chronic pelvic pain syndrome 1
  • Test-of-cure is not recommended for asymptomatic patients who received recommended treatment 1
  • Consider repeat testing 3-6 months after treatment due to high rate of reinfection 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Persistent Urethritis Despite Doxycycline Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.